Meldungen sortieren nach Relevanz Meldungsdatum
|
Roche Launches 454 Sequencing Assays for High Sensitivity Genetic Variant Detection in Leukemia Samples to Drive Blood Cancer Research Worldwide
, Biotechnik, Roche Diagnostics GmbH
Roche announced today the launch and immediate availability of the GS GType TET2/CBL/KRAS and the GS GType RUNX1 Primer Sets for comprehensive genetic variation...
|
Roche Launches 454 Sequencing Assays for High Sensitivity Genetic Variant Detection in Leukemia Samples to Drive Blood Cancer Research Worldwide
, Biotechnik, Roche Diagnostics GmbH
Roche announced today the launch and immediate availability of the GS GType TET2/CBL/KRAS and the GS GType RUNX1 Primer Sets for comprehensive genetic variation...
|
|
Roche NimbleGen and BGI develop advanced MHC region capture technology for human disease and biomedical research
, Forschung und Entwicklung, Roche Diagnostics GmbH
Roche NimbleGen, Inc. and BGI, the world's largest genomic organization, announced that they have developed a Major Histocompatibility Complex (MHC) region capture...
|
|
Using Roche's CASY Cell Counter and Analyzer for proliferation and viability measurement in cancer studies
, Forschung und Entwicklung, Roche Diagnostics GmbH
In a recent study (1), Prokop et al. used the CASY Cell Counter and Analyzer from Roche Applied Science (SIX: RO, ROG; OTCQX: RHHBY) to identify the specific anticancer...
|
|
International Research Studies Underscore Utility, Robustness of 454 Sequencing Systems for Characterizing Blood Cancers
, Forschung und Entwicklung, Roche Diagnostics GmbH
Results from a series of studies presented this week at the 52nd American Society of Hematology Annual Meeting in Orlando, Florida highlight the value of high-throughput...
|
|
454 Sequencing Systems and NimbleGen Sequence Capture Show Promise for Genetic Characterization of Leukemia
, Biotechnik, Roche Diagnostics GmbH
This week at the 51st American Society for Hematology Annual Meeting, a team of researchers from the MLL Munich Leukemia Laboratory presented results from a series...
|
|
Roche NimbleGen CGH Microarrays Further Our Understanding of Childhood Acute Lymphoblastic Leukemia
, Biotechnik, Roche Diagnostics GmbH
The most commonly diagnosed form of childhood leukemia, acute lymphoblastic leukemia (ALL), often responds well to biologically-targeted therapeutic treatments,...
|
|
250th Peer-reviewed Publication Documents the Success of 454 Sequencing
, Biotechnik, Roche Diagnostics GmbH
454 Life Sciences, a Roche company, today announced the publication of the 250th peer-reviewed study using the Genome Sequencer System. Researchers are taking advantage...
|
|
Genome Sequencer FLX System plus NimbleGen Sequence Capture Arrays Help Unravel the Cryptic Genetic Changes in Hematological Malignancies
, Biotechnik, Roche Diagnostics GmbH
The Cancer Genomics Group at Barts and The London Medical School is researching leukemia with the aquisition of the state-of-the-art Genome Sequencer FLX System...
